- Home
- LTRN vs MYO Comparison
LTRN vs MYO Comparison
Compare LTRN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRN | MYO |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 36.9M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LTRN | MYO |
|---|---|---|
| Price | $2.32 | $0.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $25.00 | $7.67 |
| AVG Volume (30 Days) | 45.3K | ★ 413.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | N/A | $21.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $2.34 | $0.63 |
| 52 Week High | $5.74 | $5.62 |
Technical Indicators
Market Signals| Indicator | LTRN | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 31.37 | 44.04 |
| Support Level | N/A | $0.64 |
| Resistance Level | $3.65 | $1.03 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 1.45 | 42.38 |
Price Performance
Historical ComparisonAbout LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).